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Experimental 
 
1. Materials and Chemicals 
Ferric chloride hexahydrate (FeCl3 • 6H2O), ferrous chloride tetrahydrate (FeCl2 • 
4H2O), oleic acid (OA), styrene (St), tetraethoxysilane (TEOS), sodium dodecyl sulfate (SDS), 
hexadecane (HD), 4,4’-azobis(4-cyanovaleric acid) (ACVA), triethylamie (TEA), folic acid 
(FA), 3-(triethoxysilyl)propyl isocyanat, adipic acid dihydrazide, trifluoroacetic acid (TFA), 
Hank's Balanced Salts, sodium bicarbonate, D-(+)-glucose, and 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) were purchased from Sigma-Aldrich (USA).  
Diethyether, tetrahydrofuran (THF), ammonium hydroxide (NH4OH, 29.79 wt%),  phosphate 
buffered saline (PBS), and the DMEM media with high glucose (Hyclone) were purchased 
from Fisher Scientific (USA). 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide HCl (EDC) 
and N-Hydroxysuccinimide (NHS) were purchased from Thermo Fisher Scientific 
(USA).  Poly(ethylene glycol) bis-amine with molecular weights of 1000 Da (NH2-PEG-NH2) 
was obtained from YareBio (China). Doxorubicin hydrochloride (DOX) was purchased from 
Meiji Seika Kaisha, Ltd. (Tokyo, Japan). Acetate buffer solutions (10mM) were prepared in 
our laboratory. The human breast cancer cell line MDA-MB-231 was obtained from 
American Type Culture Collection (ATCC) and cultured in DMEM with high glucose 
supplemented with 10% fetal bovine serum, 1% MEM-Non Essential Amino Acids , 1% 
Penicillin Streptomycin, and 1% l-glutamine. HBSS buffer was made by dissolving Hank's 
Balanced Salts (0.98 %), sodium bicarbonate (0.037 %), D-(+)-glucose (0.35 %), and HEPES 
(0.286 %) in autoclaved water and titrating pH to 7.35 with NaOH. Assay material CellTiter-
Glo™ Luminescent Cell Viability Assay Kit was purchased from Promega (Madison, WI). 
Styrene monomer was washed with 5 wt% sodium hydroxide solution and stored at -20 °C 
before use. All other chemical were used as received. Deionized (DI) water was used through 
the entire experiment. Ultra high purity nitrogen gas was obtained from Wright Brother Gas 
(Cincinnati, OH). 
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2. Methods 
2.1. Synthesis of Oleic Acid Functionalized Iron Oxide Nanoparticles (OAIOs) 
Oleic acid surface functionalized iron oxide nanoparticles (~10 nm) (OAIOs) were 
fabricated using a reported method in our previous paper
[1]
. Briefly, FeCl2 • 4H2O (7.72 g) and 
FeCl3 • 6H2O (24g) were dissolve in 100 ml of DI water. The dispersion was heated to 80 °C 
with nitrogen bubbling for 0.5 h followed by addition of NH4OH (50g). Then 3.76 g of oleic 
acid was added and the dispersion was kept at 80 °C for 3 h. The dispersion was cooled to 
room temperature and OAIOs were obtained after washing with ethanol and DI water. The 
OAIOs were dispersed in octane and dried under rotary evaporation for further use.   
2.2. Fabrication of Polystyrene/Fe3O4@SiO2 Superparamagnetic Janus Nanocomposites 
(SJNCs) 
The water phase was formed by dissolving 0.092 g of SDS in 39 g of DI water. The oil 
phase was prepared by dissolving 25 mg of OAIOs, 0.4 g of HD and 2 g of TEOS in 8 g of St 
monomer. Then the oil phase was injected dropwise into the water phase under sonication, 
followed by mechanical stirring at 250 rpm for 0.5 h. The miniemulsion droplets were formed 
by sonicating the emulsions for 10 min at 500 W at a duty cycle of 50 % using a Scientz-IID 
sonifier (Ningbo, China) in an ice bath before the miniemulsion system was transferred to a 
three-neck flask. After 0.12 g of ACVA was neutralized by 1ml of NaOH solution (0.856 M) 
and added into the flask, the system was deoxygenized by nitrogen bubbling for 0.5 h with 
250 rpm mechanical stirring. Then the flask was moved into an 80 °C water bath with a 
condenser under nitrogen protection to initiate St monomer polymerization. After 60min, 50 
ul of NH4OH was added into the reaction. After another 5 h, the reaction system was taken 
out of water bath and stirred at room temperature overnight. Finally, Polystyrene/Fe3O4@SiO2 
superparamagnetic Janus nanocomposites (SJNCs) were purified by washing with DI water 
using an external magnetic field and dried under vacuum at room temperature. The SJNCs 
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were readily dual functionalized with carboxyl groups on polystyrene (PS) surface and 
hydroxyl groups on silica surface. 
2.3 Synthesis of NH2-PEG-FA and further conjugation onto Polystyrene Surface of 
SJNCs 
 Folic acid was conjugated to the NH2-PEG-NH2 through a carbodiimide-mediated 
coupling reaction. In a typical reaction, 50 mg of NH2-PEG-NH2 was dissolved in 8 ml of 
DMSO. Then 22 mg of folic acid, 47.8 mg of EDC and 15 mg of NHS were dissolved in 10ml 
of DMSO followed by addition of 20 ul of TEA and the mixture was magnetically stirred for 
1 h.  The resulting yellow solution was added dropwise (one drop per 2 secs) into the NH2-
PEG-NH2 solution under vigorous stirring and the reaction mixture was stirred overnight 
before DMSO was removed under reduced pressure at 80 °C. The yellow oily residue was 
dissolved in THF and NH2-PEG-FA was obtained by precipitation after the addition of 
diethyether.  
For conjugation of NH2-PEG-FA onto the PS surface of SJNCs, 40 mg of SJNCs were 
dispersed in 10 ml of DI water, followed by dissolution of 80 mg of EDC. The suspension 
was stirred for 15 min. Then, 12 mg of NHS and 15 mg of NH2-PEG-FA were added. The 
reaction system was stirred overnight and subjected to magnetic wash until no absorbance can 
be detected at 270 nm in the supernatant by UV-Vis spectroscopy. The resulting FA-
PS/Fe3O4@SiO2 nanocomposites (FA-SJNCs) were dried under vacuum at room temperature. 
2.4. Synthesis of Silane-hydrazide Crosslinker and Surface Modification of Silica Shell 
of SJNCs 
 In a typical reaction, 52.26 mg of adipic acid dihydrazide was dissolved in 4 ml of 
DMSO. Then 74.2 ul of 3-(Triethoxysilyl)propyl isocyanat was dissolved in 500 ul of DMSO 
and added into the adipic acid dihydrazide solution dropwise (one drop per 10 secs) under 
vigorous stirring. After reaction overnight, DMSO was removed under reduced pressure at 
80 °C and the waxy residue was dissolved in 2 ml of EtOH. 
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 A standard silane coupling method was employed to modify the silica surface. 40 mg 
of FA-NPs were dispersed in 16 ml of EtOH/H2O (95:5) mixture. The 60 ul of the above 
silane-hydrazide solution in EtOH was added into the FA-SJNCs dispersion under stirring. 
The pH was tuned to 5 by HCl and the dispersion was stirred for 4 h at room temperature. 
Then the pH was tuned to neutral by adding NaOH and stirred overnight. The surface 
modified FA-SJNCs-NHNH2 nanocomposites were washed by magnetic separation with 
EtOH and DI water for four times respectively and dried at room temperature under vacuum 
for drug loading. 
2.5. Doxorubicin loading onto FA-SJNCs-NHNH2 Nanocomposites 
 DOX was conjugated to the surface of silica half shell through the formation of 
hydrazone bonds. Briefly, 35 mg of FA-SJNCs-NHNH2 nanocomposites were dispersed in 15 
ml of DOX solution in anhydrous methonal (0.33 mg ml
-1
) and 3 ul of TFA was added to tune 
the pH to 5. The mixture was stirred in darkness for 40 h at room temperature and intense 
magnetic wash with anhydrous methanol was carried out till no absorbance at 480 nm was 
detected in the supernatant on a UV-Vis spectrophotometer. The FA-SJNCs-DOX conjugates 
were dried at room temperature under vacuum. 
2.6. Evaluation of pH sensitivity 
 The pH-responsive DOX release profile from the FA-SJNCs-DOX conjugates was 
studied using UV-Vis spectrophotometer. First, 10mg of FA-SJNCs-DOX conjugates were 
dispersed in 5 ml of buffer solutions of different pH conditions [PBS buffer, pH 7.4 and 
acetate buffer (pH 5.0 and 6.0)] in glass vials and placed on an electric rotator in an incubator 
set at 37 °C. At selected time intervals, 1 ml of supernatant was removed from the vial after 
magnetic wash and replaced by fresh buffer solution with the same volume. The absorbance 
of released DOX was measured by a UV-Vis spectrophotometer at 480 nm and the amount 
was calculated according to a pre-established DOX calibration curve.  
2.7. In-vitro Cell Cytotoxicity Assay 
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 The cytotoxicity of SJNCs-DOX conjugates against the MDA-MB-231 cell was 
studied using the luminescent ATP-based assay kit (CellTiter GLO, Promega, Madison, WI) 
according to the manufacturer's instructions. First, MDA-MB-231 cells were seeded (2500 
cells per well) in 96-well plates for 24 h. Then, the media was replaced with HBSS buffer 
solution containing free DOX, FA-SJNCs-NHNH2, FA-SJNCs-DOX, and SJNCs-DOX. For 
competition experiments, 1 mM of folic acid was included as inhibitor into the HBSS buffer 
solution. Cells were incubated for 4 h, washed with warm HBSS buffer twice and further 
incubated with serum-containing media for another 48 h. Luminescence was measured using a 
BMG PolarSTAR microplate reader. All experiments were performed at least in triplicate. 
Results are expressed as mean ± standard deviation. Statistical comparison between 
experimental groups was performed using Students t-test at a significance level of p < 0.05 
(GraphPad Prism 5).  
3. Characterization 
 The morphology of SJNCs was observed on a Philips Tecnai 20 transmission electron 
microscope with an accelerating voltage of 200 kV. The STEM images and elemental 
mapping were obtained on a Zeiss Ultra55 equipped with Oxford Aztec X-Max 50 EDS 
system operated at an accelerating voltage of 1 kV. Size distribution of SJNCs dispersed in DI 
water was measured using a Malvern Zetasizer (Nano ZS).  Thermal gravimetric analysis 
(TGA) analysis was performed on a thermogravimetric analyzer (NETZSCH TG209) under 
nitrogen atmosphere. The magnetic properties were measured at room temperature using a 
Vibrating Sample Magnetometer (VSM 7407, Lake Shore, USA). FTIR spectra were recorded 
with a Nicolete 6700 FTIR from Thermo Scientific using the KBr method. UV-Vis spectra 
were recorded on a Hitachi U-3000 spectrophotometer using a cuvette with the path length of 
1 cm. Luminescence was obtained on a POLARstar OPTIMA microplate reader (BMG 
Labtechnologies, Chicago, USA). 
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Figure S1. DLS data of SJNCs in DI water. 
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Figure S2. TGA curve of SJNCs. 
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Figure S3. Schematic drawing of (a) folic acid (FA) conjugation and (b) doxorubicin (DOX) 
loading onto SJNCs dual surfaces. 
 
Table S1. Estimated IC50 values for free DOX, FA-targeted SJNCs-DOX in the presence and 
absence of 1 mM FA, and non-targeted SJNCs-DOX using human MDA-MB-231 breast 
cancer cells. 
 DOX FA-SJNCs-
DOX 
FA-SJNCs-DOX-
FA Competition 
SJNCs-DOX 
IC50 [µg ml
-1
] 3.3 ± 0.3 255.3 ± 55.1 781.2 ± 163.0 1030.2 ± 416.1 
 
